Insight Molecular Diagnostics Inc. Operating Income
Insight Molecular Diagnostics Inc. (IMDX) reported Operating Income of -$11.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. operating income (loss) for the quarter ending 2026-06-30 was -$11.40M.
- Insight Molecular Diagnostics Inc. operating income (loss) for the quarter ending 2026-03-31 was -$4.41M.
- Insight Molecular Diagnostics Inc. operating income (loss) for the quarter ending 2025-12-31 was -$23.43M.
- Insight Molecular Diagnostics Inc. operating income (loss) for the quarter ending 2025-09-30 was -$11.05M.
- Insight Molecular Diagnostics Inc. operating income (loss) for fiscal 2025 was -$51.12M.
- Insight Molecular Diagnostics Inc. operating income (loss) for fiscal 2024 was -$61.04M.
- Insight Molecular Diagnostics Inc. operating income (loss) for fiscal 2023 was -$25.14M.
- Insight Molecular Diagnostics Inc. operating income (loss) for fiscal 2022 was -$18.00M.
| Period end | Operating Income (Loss) 2 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.40M 10-Q · filed 2026-08-10 | -$15.81M 10-Q · filed 2026-08-10 | -$39.25M derived: sum of 3 quarters · filed 2026-08-10 | -$50.30M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2026-03-31 | -$4.41M 10-Q · filed 2026-05-13 | -$27.85M derived: sum of 2 quarters · filed 2026-05-13 | -$38.90M derived: sum of 3 quarters · filed 2026-05-13 | -$48.74M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-12-31 | -$23.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$34.48M derived: sum of 2 quarters · filed 2026-03-26 | -$44.33M derived: sum of 3 quarters · filed 2026-08-10 | -$51.12M 10-K · filed 2026-03-26 | |||||
| 2025-09-30 | -$11.05M 10-Q · filed 2025-11-10 | -$20.89M derived: sum of 2 quarters · filed 2026-08-10 | -$27.69M 10-Q · filed 2025-11-10 | -$61.32M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-06-30 | -$9.84M 10-Q · filed 2026-08-10 | -$16.64M 10-Q · filed 2026-08-10 | -$50.27M derived: sum of 3 quarters · filed 2026-08-10 | -$63.78M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-03-31 | -$6.80M 10-Q · filed 2026-05-13 | -$40.43M derived: sum of 2 quarters · filed 2026-05-13 | -$53.94M derived: sum of 3 quarters · filed 2026-05-13 | -$58.57M derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | -$33.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$47.14M derived: sum of 2 quarters · filed 2026-03-26 | -$51.77M derived: sum of 3 quarters · filed 2026-03-26 | -$61.04M 10-K · filed 2026-03-26 | |||||
| 2024-09-30 | -$13.52M 10-Q · filed 2025-11-10 | -$18.15M derived: sum of 2 quarters · filed 2025-11-10 | -$27.41M 10-Q · filed 2025-11-10 | -$43.59M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2024-06-30 | -$4.63M 10-Q · filed 2025-08-11 | -$13.90M 10-Q · filed 2025-08-11 | -$30.08M derived: sum of 3 quarters · filed 2025-08-11 | -$36.59M derived: sum of 4 quarters · filed 2025-08-11 | |||||
| 2024-03-31 | -$9.27M 10-Q · filed 2025-05-12 | -$25.45M derived: sum of 2 quarters · filed 2025-05-12 | -$31.96M derived: sum of 3 quarters · filed 2025-05-12 | -$40.25M derived: sum of 4 quarters · filed 2025-05-12 | |||||
| 2023-12-31 | -$16.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$22.69M derived: sum of 2 quarters · filed 2025-03-24 | -$30.99M derived: sum of 3 quarters · filed 2025-03-24 | -$25.14M 10-K · filed 2025-03-24 | |||||
| 2023-09-30 | -$6.51M 10-Q · filed 2024-11-12 | -$14.81M derived: sum of 2 quarters · filed 2024-11-12 | -$8.96M 10-Q · filed 2024-11-12 | -$20.61M derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | -$8.29M 10-Q · filed 2024-08-08 | -$2.44M 10-Q · filed 2024-08-08 | -$14.09M derived: sum of 3 quarters · filed 2024-08-08 | -$15.80M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | $5.85M 10-Q · filed 2024-05-15 | $5.80M 10-Q · filed 2023-05-15 | -$5.80M derived: sum of 2 quarters · filed 2024-05-15 | -$7.50M derived: sum of 3 quarters · filed 2024-05-15 | -$9.13M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$11.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$13.35M derived: sum of 2 quarters · filed 2024-04-16 | -$14.98M derived: sum of 3 quarters · filed 2024-04-16 | -$18.00M 10-K · filed 2024-04-16 | |||||
| 2022-09-30 | -$1.71M 10-Q · filed 2023-11-09 | -$9.22M 10-Q · filed 2022-11-10 | -$3.33M derived: sum of 2 quarters · filed 2023-11-09 | -$6.35M 10-Q · filed 2023-11-09 | -$27.68M 10-Q · filed 2022-11-10 | -$42.03M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$1.63M 10-Q · filed 2023-08-10 | -$8.56M 10-Q · filed 2022-08-12 | -$4.64M 10-Q · filed 2023-08-10 | -$18.46M 10-Q · filed 2022-08-12 | -$40.32M derived: sum of 3 quarters · filed 2023-08-10 | -$53.93M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$3.02M 10-Q · filed 2023-05-15 | -$9.89M 10-Q · filed 2022-05-12 | -$38.70M derived: sum of 2 quarters · filed 2023-05-15 | -$52.30M derived: sum of 3 quarters · filed 2023-05-15 | -$65.87M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$35.68M 10-K · filed 2022-03-11 | -$49.28M derived: sum of 2 quarters · filed 2022-11-10 | -$62.85M derived: sum of 3 quarters · filed 2022-11-10 | -$53.73M 10-K · filed 2023-04-12 | -$74.21M 10-K · filed 2022-03-11 | ||||
| 2021-09-30 | -$13.60M 10-Q · filed 2022-11-10 | -$27.17M derived: sum of 2 quarters · filed 2022-11-10 | -$38.53M 10-Q · filed 2022-11-10 | -$44.80M derived: sum of 4 quarters · filed 2022-11-10 | |||||
| 2021-06-30 | -$13.57M 10-Q · filed 2022-08-12 | -$24.93M 10-Q · filed 2022-08-12 | -$31.20M derived: sum of 3 quarters · filed 2022-08-12 | -$37.44M derived: sum of 4 quarters · filed 2022-08-12 | |||||
| 2021-03-31 | -$11.36M 10-Q · filed 2022-05-12 | -$17.63M derived: sum of 2 quarters · filed 2022-05-12 | -$23.87M derived: sum of 3 quarters · filed 2022-05-12 | -$32.64M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2021-02-23 | -$125.00K 10-K · filed 2022-03-11 | ||||||||
| 2020-12-31 | -$6.27M 10-K · filed 2022-03-11 | -$12.51M derived: sum of 2 quarters · filed 2022-03-11 | -$21.28M derived: sum of 3 quarters · filed 2022-03-11 | -$29.71M 10-K · filed 2022-03-11 | |||||
| 2020-09-30 | -$6.24M 10-K · filed 2022-03-11 | -$15.01M derived: sum of 2 quarters · filed 2022-03-11 | -$23.44M 10-Q · filed 2021-11-09 | -$30.97M derived: sum of 4 quarters · filed 2022-03-11 | |||||
| 2020-06-30 | -$8.77M 10-K · filed 2022-03-11 | -$17.20M 10-Q · filed 2021-08-11 | -$24.72M derived: sum of 3 quarters · filed 2022-03-11 | -$29.98M derived: sum of 4 quarters · filed 2022-03-11 | |||||
| 2020-03-31 | -$8.43M 10-K · filed 2022-03-11 | -$15.95M derived: sum of 2 quarters · filed 2022-03-11 | -$21.21M derived: sum of 3 quarters · filed 2022-03-11 | -$26.67M derived: sum of 4 quarters · filed 2022-03-11 | |||||
| 2019-12-31 | -$7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | -$12.78M derived: sum of 2 quarters · filed 2021-03-19 | -$18.24M derived: sum of 3 quarters · filed 2021-03-19 | -$22.24M 10-K · filed 2021-03-19 | |||||
| 2019-09-30 | -$5.26M 10-Q · filed 2020-11-12 | -$10.72M derived: sum of 2 quarters · filed 2020-11-12 | -$14.72M 10-Q · filed 2020-11-12 | -$18.76M derived: sum of 4 quarters · filed 2020-11-12 | |||||
| 2019-06-30 | -$5.46M 10-Q · filed 2020-07-29 | -$9.46M 10-Q · filed 2020-07-29 | -$13.51M derived: sum of 3 quarters · filed 2020-07-29 | -$16.53M derived: sum of 4 quarters · filed 2020-07-29 | |||||
| 2019-03-31 | -$4.00M 10-Q · filed 2020-05-12 | -$8.04M derived: sum of 2 quarters · filed 2020-05-12 | -$11.07M derived: sum of 3 quarters · filed 2020-05-12 | -$15.29M derived: sum of 4 quarters · filed 2020-05-12 | |||||
| 2018-12-31 | -$4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$7.07M derived: sum of 2 quarters · filed 2020-03-26 | -$11.30M derived: sum of 3 quarters · filed 2020-03-26 | -$15.20M 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | -$3.02M 10-Q · filed 2019-11-14 | -$7.25M derived: sum of 2 quarters · filed 2019-11-14 | -$11.15M 10-Q · filed 2019-11-14 | -$15.05M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | -$4.23M 10-Q · filed 2019-08-14 | -$8.13M 10-Q · filed 2019-08-14 | -$12.02M derived: sum of 3 quarters · filed 2019-08-14 | -$18.86M derived: sum of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | -$3.91M 10-Q · filed 2019-05-14 | -$7.80M derived: sum of 2 quarters · filed 2019-05-14 | -$14.63M derived: sum of 3 quarters · filed 2019-05-14 | -$18.22M derived: sum of 4 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$10.73M derived: sum of 2 quarters · filed 2019-04-01 | -$14.32M derived: sum of 3 quarters · filed 2019-04-01 | -$18.85M 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | -$6.83M 10-Q · filed 2018-11-13 | -$10.42M derived: sum of 2 quarters · filed 2018-11-13 | -$14.96M 10-Q · filed 2018-11-13 | -$18.05M derived: sum of 4 quarters · filed 2018-11-13 | |||||
| 2017-06-30 | -$3.59M 10-Q · filed 2018-08-14 | -$8.12M 10-Q · filed 2018-08-14 | -$11.21M derived: sum of 3 quarters · filed 2018-08-14 | -$13.80M derived: sum of 4 quarters · filed 2018-08-14 | |||||
| 2017-03-31 | -$4.53M 10-Q · filed 2018-05-15 | -$7.63M derived: sum of 2 quarters · filed 2018-05-15 | -$10.21M derived: sum of 3 quarters · filed 2018-05-15 | -$12.74M derived: sum of 4 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | -$3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$5.68M derived: sum of 2 quarters · filed 2018-04-02 | -$8.21M derived: sum of 3 quarters · filed 2018-04-02 | -$11.14M 10-K · filed 2018-04-02 | |||||
| 2016-09-30 | -$2.58M 10-Q · filed 2017-11-14 | -$5.11M derived: sum of 2 quarters · filed 2017-11-14 | -$8.05M 10-Q · filed 2017-11-14 | -$11.59M derived: sum of 4 quarters · filed 2018-04-02 | |||||
| 2016-06-30 | -$2.53M 10-Q · filed 2017-08-14 | -$5.46M 10-Q · filed 2017-08-14 | -$9.00M derived: sum of 3 quarters · filed 2018-04-02 | -$11.41M derived: sum of 4 quarters · filed 2018-04-02 | |||||
| 2016-03-31 | -$2.93M 10-Q · filed 2017-04-28 | -$6.47M derived: sum of 2 quarters · filed 2018-04-02 | -$8.88M derived: sum of 3 quarters · filed 2018-04-02 | -$10.28M derived: sum of 4 quarters · filed 2018-04-02 | |||||
| 2015-12-31 | -$3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$5.95M derived: sum of 2 quarters · filed 2018-04-02 | -$7.35M derived: sum of 3 quarters · filed 2018-04-02 | -$8.72M 10-K · filed 2018-04-02 | |||||
| 2015-09-30 | -$2.41M 10-Q · filed 2016-11-10 | -$3.81M derived: sum of 2 quarters · filed 2016-11-10 | -$5.18M 10-Q · filed 2016-11-10 | ||||||
| 2015-06-30 | -$1.41M 10-Q · filed 2016-08-11 | -$2.77M 10-Q · filed 2016-08-11 | |||||||
| 2015-03-31 | -$1.37M 10-Q · filed 2016-05-16 | ||||||||
| 2014-12-31 | -$4.97M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |